DexCom (XTRA:DC4) Price Target Decreased by 12.36% to 77.50

The average one-year price target for DexCom (XTRA:DC4) has been revised to 77,50 € / share. This is a decrease of 12.36% from the prior estimate of 88,43 € dated November 9, 2025.

The price target is an average of many targets provided by analysts. The latest targets range from a low of 55,85 € to a high of 103,22 € / share. The average price target represents an increase of 54.45% from the latest reported closing price of 50,18 € / share.

What is the Fund Sentiment?

There are 1,831 funds or institutions reporting positions in DexCom. This is an decrease of 20 owner(s) or 1.08% in the last quarter. Average portfolio weight of all funds dedicated to DC4 is 0.27%, an increase of 0.60%. Total shares owned by institutions decreased in the last three months by 1.32% to 439,472K shares.

What are Other Shareholders Doing?

Baillie Gifford holds 15,882K shares representing 4.07% ownership of the company. In its prior filing, the firm reported owning 16,705K shares , representing a decrease of 5.18%. The firm decreased its portfolio allocation in DC4 by 74.63% over the last quarter.

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 12,623K shares representing 3.24% ownership of the company. In its prior filing, the firm reported owning 12,360K shares , representing an increase of 2.09%. The firm increased its portfolio allocation in DC4 by 16.47% over the last quarter.

VFINX - Vanguard 500 Index Fund Investor Shares holds 11,131K shares representing 2.85% ownership of the company. In its prior filing, the firm reported owning 10,858K shares , representing an increase of 2.45%. The firm increased its portfolio allocation in DC4 by 16.41% over the last quarter.

Geode Capital Management holds 10,964K shares representing 2.81% ownership of the company. In its prior filing, the firm reported owning 10,766K shares , representing an increase of 1.80%. The firm decreased its portfolio allocation in DC4 by 62.04% over the last quarter.

Jennison Associates holds 10,090K shares representing 2.59% ownership of the company. In its prior filing, the firm reported owning 11,518K shares , representing a decrease of 14.14%. The firm decreased its portfolio allocation in DC4 by 64.89% over the last quarter.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.